Journal
ENDOCRINOLOGY
Volume 146, Issue 11, Pages 4657-4664Publisher
ENDOCRINE SOC
DOI: 10.1210/en.2005-0804
Keywords
-
Categories
Funding
- MRC [MC_U127684438] Funding Source: UKRI
- Medical Research Council [U.1276.00.004.00002.01/2(61014), MC_U127684438] Funding Source: Medline
- Medical Research Council [MC_U127684438] Funding Source: researchfish
Ask authors/readers for more resources
Cyclooxygenase ( COX) enzymes catalyze the biosynthesis of eicosanoids, including prostaglandin (PG) F-2 alpha. PGF(2 alpha) exerts its autocrine/paracrine function by coupling to its G protein-coupled receptor [F-series-prostanoid ( FP) receptor] to initiate cell signaling and target gene transcription. In the present study, we found elevated expression of COX-2 and FP receptor colocalized together within the neoplastic epithelial cells of endometrial adenocarcinomas. We investigated a role for PGF(2 alpha)- FP receptor interaction in modulating COX-2 expression and PGF(2 alpha) biosynthesis using an endometrial adenocarcinoma cell line stably transfected with the FP receptor cDNA (FPS cells). PGF(2 alpha)-FP receptor activation rapidly induced COX-2 promoter, mRNA, and protein expression in FPS cells. These effects of PGF(2 alpha) on the expression of COX-2 could be abolished by treatment of FPS cells with an FP receptor antagonist (AL8810) and chemical inhibitor of ERK1/2 kinase (PD98059), or by inactivation of ERK1/2 signaling with dominant-negative mutant isoforms of Ras or ERK1/2 kinase. We further confirmed that elevated COX-2 protein in FPS cells could biosynthesize PGF(2 alpha) de novo to promote a positive feed-back loop to facilitate endometrial tumorigenesis. Finally, we have shown that PGF2 alpha could potentiate tumorigenesis in endometrial adenocarcinoma explants by inducing the expression of COX-2 mRNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available